Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Montelukast for status asthmaticus in children (2-5 years)
NCT00491790Phase 3Unknown
- Sponsor
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
- Start
- Dec 2006
- Primary completion
- Jan 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in status asthmaticus comparing Placebo with Montelukast (2 arms). Primary endpoint: Effectiveness of Montelukast as adjunctive therapy. Status: unknown.
02
Drugs
montelukast
03
Conditions
status asthmaticus
Beyond the preview
Go deeper on NCT00491790.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00491790.